Lexicon Pharmaceuticals LXRX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's accounts payable?
- Lexicon Pharmaceuticals (LXRX) reported accounts payable of $3M in Q1 2026.
- How has Lexicon Pharmaceuticals's accounts payable changed year-over-year?
- Lexicon Pharmaceuticals's accounts payable decreased by 72.0% year-over-year, from $10.69M to $3M.
- What is the long-term trend for Lexicon Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's accounts payable has grown at a -10.8% compound annual growth rate (CAGR), from $5.47M to $3.08M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.